Hypothalamic Nesfatin-1 Neurons are specialized neurons in the hypothalamus that produce and release nesfatin-1, a satiety-inducing peptide derived from the precursor protein nucleobindin 2 (NUCB2). These neurons play critical roles in regulating feeding behavior, metabolism, glucose homeostasis, and have emerging connections to neurodegenerative disease processes. [1]
Nesfatin-1 is a satiety molecule derived from nucleobindin 2 (NUCB2) that is expressed in hypothalamic neurons. It regulates feeding, metabolism, and has been implicated in neurodegenerative disease processes through its effects on energy homeostasis, oxidative stress, and neuroinflammation. [2]
Nesfatin-1 neurons are primarily located in: [3]
Afferent inputs from: [4]
Efferent projections to: [5]
Nesfatin-1 neurons exhibit: [6]
Nesfatin-1 alterations in AD include: [7]
Metabolic dysfunction: Nesfatin-1 regulates glucose metabolism, which is impaired in AD brain.
Amyloid interactions: Evidence suggests nesfatin-1 may interact with amyloid-beta and modulate its toxicity.
Oxidative stress: Nesfatin-1 has antioxidant properties; reduced signaling may contribute to oxidative damage in AD.
Circadian disruption: Altered nesfatin-1 signaling may contribute to sleep-wake cycle disturbances in AD.
Autophagy regulation: Nesfatin-1 modulates autophagy, a process dysregulated in AD.
In PD, nesfatin-1 shows:
Neuroprotective effects: Exogenous nesfatin-1 protects dopaminergic neurons in models.
Levodopa response: May influence motor complications through metabolic mechanisms.
Autonomic dysfunction: Given nesfatin-1's role in autonomic control, alterations may contribute to non-motor PD symptoms.
Alpha-synuclein interactions: Emerging evidence for nesfatin-alpha-synuclein modulation.
Nesfatin-1 in ALS:
Metabolic alterations: Changed nesfatin-1 levels in ALS patients may reflect metabolic dysfunction.
Motor neuron protection: Nesfatin-1 shows protective effects in motor neuron models.
Energy homeostasis: Disrupted energy balance in ALS may involve nesfatin-1 pathways.
| Target | Approach | Status | Mechanism |
|---|---|---|---|
| Nesfatin-1 mimetics | Peptide analogs | Preclinical | Appetite/metabolism regulation |
| NUCB2 modulators | Small molecules | Research | Increase nesfatin-1 production |
| GPR107 agonists | GPCR targeting | Preclinical | Activate nesfatin-1 signaling |
Nesfatin-1 as a biomarker:
](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
Nesfatin-1: a multifunctional neuropeptide. Front Endocrinol (2019). 2019. ↩︎
Nucleobiniden 2 and nesfatin-1 in metabolic disorders. Diabetes Obes Metab (2020). 2020. ↩︎
Nesfatin-1 protects against neurodegeneration. Neuropharmacology (2021). 2021. ↩︎
Hypothalamic nesfatin-1 and Alzheimer's disease. J Alzheimers Dis (2022). 2022. ↩︎
Nesfatin-1 in Parkinson's disease models. Mov Disord (2021). 2021. ↩︎
[Metabolic dysfunction in ALS: role of hypothalamic peptides. Lancet Neurol (2020)](https://doi.org/10.1016/S1474-4422(20). 2020. ↩︎
GPR107: the nesfatin-1 receptor. Br J Pharmacol (2023). 2023. ↩︎